Document Detail

Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience.
MedLine Citation:
PMID:  19574206     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: The objective was to compare the short- and long-term impact of 3 different treatment modalities on health-related quality of life (HRQOL) in patients treated for localised prostate cancer at a single centre in Catalonia, Spain. MATERIAL AND METHODS: This was a longitudinal, prospective study of 304 patients from a single centre in Catalonia, Spain. Patients underwent 1 of 3 treatment procedures: radical prostatectomy (114 patients), external beam radiation (134) or interstitial brachytherapy (56). HRQOL was assessed by both general and specific questionnaires, including the SF-36 health survey and the Expanded Prostate Cancer Index Composite (EPIC). Interviews were administered prior to treatment and at months 1, 3, 6, 12 and 24. One-way analysis of variance and generalised estimating equations models were constructed to assess between group differences in HRQOL. RESULTS: After initial deterioration, HRQOL scores partially recovered, although significant differences between treatment groups persisted at two years. Worsening of urinary incontinence was especially marked for the radical prostatectomy group (11.45, p=0.005), while deterioration in the urinary irritative/obstructive domain was worse following brachytherapy treatment (4.76, p=0.025). Decline in sexual function was significantly greater for the radical prostatectomy group than for the brachytherapy group (18.74, p<0.001). No significant between-group differences were observed in bowel domain scores. CONCLUSIONS: Quality of life 2 years after treatment for prostate cancer shows wide variability. Radical prostatectomy had the largest negative impact on the sexual and urinary incontinence domains. Differences between external radiation and brachytherapy were relatively small. Brachytherapy led to a moderate increase in urinary irritation compared to the other 2 groups.
F Guedea; M Ferrer; J Pera; F Aguil??; A Boladeras; J F Su??rez; O Cunillera; F Ferrer; Y Pardo; E Mart??nez; M Ventura
Related Documents :
17183346 - Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectil...
11108566 - Microwave thermotherapy in patients with chronic urinary retention.
16407016 - Recovery of abnormal ejaculation by intermittent tamsulosin treatment.
15182406 - Laparoscopic radical prostatectomy - results of 200 consecutive cases in a canadian med...
890266 - Treatment of critical ischaemia of the lower limb by venous arterialization : an interi...
8035916 - Comparison of intravenous penicillin g and oral doxycycline for treatment of lyme neuro...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico     Volume:  11     ISSN:  1699-3055     ISO Abbreviation:  -     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-07-03     Completed Date:  2009-12-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101247119     Medline TA:  Clin Transl Oncol     Country:  Spain    
Other Details:
Languages:  eng     Pagination:  470-8     Citation Subset:  IM    
Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Brachytherapy / adverse effects*
Health Status
Middle Aged
Prospective Studies
Prostate / pathology,  surgery
Prostatectomy / adverse effects*
Prostatic Neoplasms / radiotherapy,  surgery,  therapy*
Quality of Life*
Treatment Outcome
Urinary Incontinence / pathology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Value of the identifi cation of microsatellite instability in colorectal cancer.
Next Document:  Pre-treatment serum lactate dehydrogenase level is an important prognostic factor in high-grade extr...